Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11663146 | 0.92 | ALDH1A1 (0.39) | ALDH1A1F2PRSS1PRSS2PRSS3 | |
| SCHEMBL1218499 | 0.91 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL5704689 | 0.91 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL5693985 | 0.91 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL27496523 | 0.88 | ALDH1A1 (0.36) | ALDH1A1F2PRSS1PRSS2PRSS3 | |
| SCHEMBL11659305 | 0.87 | ALDH1A1 (0.36) | ALDH1A1NPC1MAPK1RAB9ADGAT1 | |
| SCHEMBL23910181 | 0.85 | ALDH1A1 (0.34) | ALDH1A1F2PRSS1PRSS2PRSS3 | |
| SCHEMBL8540711 | 0.84 | ALDH1A1 (0.36) | ALDH1A1F2PRSS1PRSS2PRSS3 | |
| SCHEMBL2152698 | 0.83 | ALDH1A1 (0.38) | ALDH1A1NPC1MAPK1RAB9ADGAT1 | |
| SCHEMBL22142472 | 0.83 | ALDH1A1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2024054920-A1 | LITHIUM ION COMPLEXES AND THE USE IN ELECTROCHEMICAL DEVICES CONTAINING THE SAME | II-VI DELAWARE, INC. (US) | 2024-03-14 | — | — | WO | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-5874469-A | DRUG VEHICLE | ALCON LABORATORIES, INC. (US) | 1999-02-23 | — | — | US | claimed |
| US-20260100416-A1 | Electrolyte Composition | II VI DELAWARE INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4723184-A1 | ELECTROLYTE COMPOSITION | II-VI Delaware, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| EP-4498449-A2 | FLUORINATED ELECTROLYTE COMPOSITION FOR CHALCOGEN BATTERY | II-VI Delaware, Inc. (US) | 2025-01-29 | — | — | EP | disclosed |
| US-20250006999-A1 | Fluorinated Electrolyte Composition for Chalcogen Battery | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2025-01-02 | — | — | US | disclosed |
| CN-118126599-A | Drag-reducing coating and preparation method and application thereof | 南京佳乐船舶设备有限公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024054920-A1 | LITHIUM ION COMPLEXES AND THE USE IN ELECTROCHEMICAL DEVICES CONTAINING THE SAME | II-VI DELAWARE, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20020048724-A1 | Polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
| US-20020004569-A1 | Polymer, chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-01-10 | — | — | US | disclosed |
| US-20010038969-A1 | Novel polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. OF (JP) | 2001-11-08 | — | — | US | disclosed |
| US-20010033989-A1 | Novel polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| US-20010018162-A1 | Novel polymers, chemical amplification resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-08-30 | — | — | US | disclosed |
| EP-1126322-A2 | Fluorine-containing polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260100416-A1 | Electrolyte Composition | KCNN2, KCNN1, HCN2 | ALDH1A1 1436/4885NPC1 3091/4885MAPK1 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.